Gynecology at IgMin Research | Medicine Group

Our mission is to foster interdisciplinary dialogue and accelerate the advancement of knowledge across a wide spectrum of scientific domains.


Gynecology is a specialized medical field focused on the health and well-being of the female reproductive system. Gynecologists are experts in diagnosing and treating a wide range of conditions that affect women's reproductive organs, including the uterus, ovaries, fallopian tubes, and breasts. Their expertise spans from routine gynecological care to managing complex reproductive health issues.

The study of gynecology involves understanding the intricacies of the female reproductive system, hormonal changes, and the diagnosis and treatment of various gynecological conditions. Gynecologists provide preventive care, family planning guidance, and treatment for conditions such as menstrual disorders, infertility, and gynecological cancers. By addressing both medical and emotional aspects, gynecology plays a vital role in promoting women's health and well-being.

  • Routine Gynecological Examinations
  • Family Planning and Birth Control
  • Menstrual and Hormonal Disorders
  • Reproductive Health Counseling
  • Preconception and Pregnancy Care
  • Infertility Evaluation and Treatment
  • Gynecological Cancers
  • Pelvic Floor Health
  • Menopause Management
  • Endometriosis and Fibroids
  • Adolescent Gynecology
  • Sexual Health and Wellness
  • Reproductive Surgery
  • Minimally Invasive Gynecological Procedures
  • Breast Health and Screening
  • Urogynecology
  • Fertility Preservation
  • Reproductive Genetics
  • Gynecology Research and Innovations
  • Telemedicine in Gynecology
  • Ethical Considerations in Women's Health
  • Cultural Sensitivity in Gynecology
  • Reproductive Health Education
  • Women's Health Advocacy
  • Continuing Medical Education in Gynecology

Medicine Group (1)

Research Article Article ID: igmin188

Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.

A Study to Determine the Reason for Lower Pregnancy Rates in Younger Women with Diminished Oocyte Reserve-less Chance of Implanting vs. Fetal Demise
by Jerome H Check, Brooke Neumann, Diane L Check and Michael Sobel

Most studies find lower live-delivered pregnancy rates (LDPRs) following in vitro fertilization-embryo transfer (IVF-ET) in women with diminished oocyte reserve (DOR) vs. normal oocyte reserve (NOR) even in a younger population. How much of a discrepancy may depend on the degree of oocyte depletion in the DOR group and the follicular stimulation protocol. Some fertility specialists favor an FSH receptor up-regulation technique as the protocol to attain the maximum LDPRs in women with DOR. The objective of this study was to compare chemical, cli...nical, and LDPRs following IVF-ET to determine if the main time of embryo loss is very early, as evidenced by the largest discrepancy occurring in attaining even a chemical pregnancy, and/ or a large discrepancy between a chemical pregnancy and attaining a clinical pregnancy (ultrasound evidence of a gestational sac) or later losses as evidenced by showing a greater loss rate from clinical evidence of pregnancy to live delivery in those with DOR compared to NOR. Overall, the DOR group, with a mean serum anti-Mullerian hormone (AMH) level of 0.42 ng/mL, had 50% as much chance to have an LDPR/transfer as women with NOR (AMH of 4.66) despite the same number of day 3 embryos transferred. The main reduction in LDPRs occurred from embryo transfer failing to attain a positive clinical pregnancy in the DOR group. The least discrepancy was from attaining a clinical pregnancy to live delivery. Thus, for NOR from positive pregnancy test 59% of this younger age group will have a live delivery vs. 50% for DOR. Thus, the reduction in LDPRS/transfer in young women with DOR vs. NOR seems mostly very early so the DOR group does not even attain a positive serum beta human chorionic gonadotropin level. This suggests that this inferiority in attaining a live delivery may be related to aneuploidy involving large chromosomes or a marked decrease in the mitochondrial DNA of the embryo.